100 likes | 354 Views
Biodefense-related Research UMDNJ-New Jersey Medical School. Nancy Connell, Ph.D. Director, UMDNJ Center for Biodefense Vice-chair for Research Department of Medicine. MOU With NYC. Newark: MMRS. Renew MOU With NYC. HHS funding (NJDoHSS) 2002, 2003. Emerging Pathogens 1999. DoD
E N D
Biodefense-related ResearchUMDNJ-New Jersey Medical School Nancy Connell, Ph.D. Director, UMDNJ Center for Biodefense Vice-chair for Research Department of Medicine
MOU With NYC Newark: MMRS Renew MOU With NYC HHS funding (NJDoHSS) 2002, 2003 Emerging Pathogens 1999 DoD funding 2000 DoD funding 2001 Incident Support And Operational Planning (2002) Member:Domestic Preparedness Task Force - NJ WMD first- Responder training BT annex Univ. Hospital plan: State model NIH- Regional Center of Excellence in Biodefense UH-EMS Anthrax attacks “Public Health War College” 9-11 Center for Biodefense Mobilization of expertise MOU NJDoH INFORM ICPH (PHRI) HRSA Funding 2003 Regional Biocontainment Laboratory DoD funding 2002,2003
Biological Agent Research Capacity in Newark • Center for Emerging and Re-emerging Pathogens (NJMS) • International Center • for Public Health • NJMS Microbiology • NJMS Nat’l TB Center • Public Health Research Inst
Bacillus anthracis Yersinia pestis Burkholderia mallei Francisella tularensis Mycobacterium tuberculosis Hantaan virus Dengue virus Monkeypox Influenza virus SARS Biological agents
Biological research areas • Diagnostics • DNA microarrays • Molecular beacons • Host response • Testing vaccine response (smallpox vaccine) • Infection models • Antibiotic resistance
DNA microarrays • Infection by different organisms will turn on and off different patterns of genes in the host. • Can we determine these patterns and use them for early diagnosis of infection?
uninfected vs virulent avirulent vs virulent 37 0 80 0 3 18 61 Total genes 44,561 uninfected vs virulent DNA microarray analysis of the host response to infection NJMS/NJDS: Gallagher Alland Raveche Schutzer CBD: Jessica Mann Paula Trzop Carolina Sofer CAG (PHRI) Pat Soteropoulos Anthony Galante NJIT Michael Recce Virginie Airis
NIH Regional Center of Excellence in Biodefense and Emerging Pathogens • Northeast Biodefense Center(among 8 of 14 applied) • Consortium of 30 institutions: NY, NJ, CT • 200 + investigators (P.I., Ian Lipkin [Columbia]) • Commissioner Lacy: advisory board • 3 New Jersey investigators on executive committee • $45 million total award (5 yrs): $ 2 million to PHRI’sDavid Perlin as animal core director • Vaccines, therapeutics, diagnostics, training • Strong emphasis on global emerging infections (SARS, West Nile)
NIH Regional Biocontainment Laboratory • Joint effort of NJMS and PHRI • $21 million award with 1/3 match by UMDNJ • 40,000 sq ft building adjacent to ICPH • University Heights Science Park • Jeannette Brummel, community liason • Brings total Newark BSL space to 22,000 sq ft
Northeast Biodefense Center CAG (PHRI) Keck Center (Rutgers) PHRI The RBL: NJMS, PHRI Beacons (NJMS, PHRI) Arrays (NJMS) NIH biodefense research priorities